Bellicum Pharmaceuticxxxpending Possible Future Eff: 03/04/24

13F holders, Q3 2025 (September 30)
1holders
1new positions
0sold out
$0.00avg. 13F price*

At the end of Q3 2025, 1 institutions reported holding Bellicum Pharmaceuticxxxpending Possible Future Eff: 03/04/24 in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 0 sold out. The largest holder was Crowley Wealth Management, Inc. ($0).

Company
Bellicum Pharmaceuticxxxpending Possible Future Eff: 03/04/24
CUSIP
079ESC026
Latest filing quarter
Q3 2025

History

Number of 13F holders

01 Q1 2024: 1Q1 2024Q3 2025: 1Q3 2025

Total Exit/New Position Q1 2024 → Q3 2025

InstitutionsTotal Value
New Positions1$0
Exits0$0

All 13F filers, Q1 2024 → Q3 2025: 11 shares bought, net +11 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Crowley Wealth Management, Inc. 0.00% New 11 $0

"% of holder's portfolio" is BELLICUM PHARMACEUTICXXXPENDING POSSIBLE FUTURE EFF: 03/04/24's weight in each manager's 13F, not the share of Bellicum Pharmaceuticxxxpending Possible Future Eff: 03/04/24 the manager owns.